Max Healthcare Institute dividend and valuation
₹902.50Change from previous close: −1.58%Absolute change: −₹14.50
Valuation
Max Healthcare Institute paid ₹2.00 per share in dividends over the last 12 months (yield 0.2%). Last ex-dividend date: July 3, 2026. The P/E ratio is 63.3. The average price target of 26 analysts is ₹1,168.50.
Data as of October 4, 2026
Valuation multiples
- Market cap
- ₹915.84B
- Enterprise value
- ₹943.9B
- P/E (trailing 12 months)
- 63.3
- Forward P/E
- 40.2
- Price/book
- 8.52
- Price/sales
- 10.5
- EV/EBITDA
- 42.0
- EV/revenue
- 10.8
Profitability and growth
- Gross margin
- 62.5%
- Operating margin
- 19.7%
- Net margin
- 16.7%
- Revenue growth (year over year)
- 16.7%
- Earnings growth (year over year)
- 4.8%
Financial health
- Total cash
- ₹6.66B
- Total debt
- ₹34.78B
- Debt/equity
- 0.32
Dividends
- Annual dividend per share
- ₹2.00
- Dividend yield
- 0.2%
- Payout ratio
- 13.4%
- Ex-dividend date
- July 3, 2026
Analysts and estimates
- Average price target
- ₹1,168.50
- Median price target
- ₹1,160.00
- High price target
- ₹1,410.00
- Low price target
- ₹825.00
- Analysts with a price target
- 26
- Consensus
- Buy
- Forward EPS
- ₹23.38
- EPS estimate, current year
- ₹18.73
Shares and trading
- Beta
- 0.11
- Average volume
- 2.12M
- Shares outstanding
- 973.31M
- Float
- 699.04M
- Institutional ownership
- 59.5%
- Insider ownership
- 28.2%